Sobre a Arthrex

Entre em contato

Arthrex.com

_blank

Veja eventos, laboratórios e oportunidades educacionais

Contacte um representante

Inscreva-se para receber: O que há de novo na Arthrex?

Full Site - Vet Systems

Calendário dos cursos

On-Demand CE

OrthoPedia Vet

Privacidade

Human

Aviso legal

Bolsas e doações

Cookie Settings

Vet Stories

Vet Systems - Large Animal

Product

Animais grandes

Team Home Templated (A)

Vet Systems - Small Animal

Animais pequenos

Vet Systems - Orthobiologics

Ortobiológicos

Vet Systems - Wound Care

Cuidados com feridas

Vet Systems - Imaging & Resection

Imagem e ressecção

Catálogo de produtos

Lista de eDFU

Formulário de solicitação para novos clientes

Facebook

Instagram

LinkedIn

Youtube

OrthoPedia Patient

SAP Supplier Portal

Área de interesse

Produtos

Educação médica

Educación médica

Corporativo

Recursos

Histórias veterinárias

Finished Product

VAR-1012

Defects in articular cartilage can induce osteoarthritis by causing molecular changes in the synovial fluid. Research in molecular biology discovered the major inducer of osteoarthritis was the general inflammatory cytokine interleukin-1 (IL-1) which plays a key role in accelerating tissue destruction and the repair mechanisms.
 
In a healthy joint, IL-1 and interleukin-1 receptor antagonist (IL-1Ra) are in balanced concentrations. In cases of osteoarthritis, there is not sufficient IL-1Ra produced to block the destructive effects of the increased IL-1. The result is inflammation, joint pain, and eventually cartilage destruction. In the IRAP II system, monocytes (a type of white blood cell) bind to the glass beads. The cells are then stimulated to produce regenerative and anti-inflammatory proteins without the addition of drugs. This process takes place over an incubation period of 24 hours.
 
IRAP II is used to treat mild to moderate osteoarthritis in animals.

IRAP II™ System

Child (D)

IRAP II CounterBalance